{
  "id": "7eb1b8269beb6439",
  "title": "Earlier Use of CDK4 / 6 Inhibitors , Oral SERDs Reflects Shift Toward Proactive Management of HR+ Breast Cancer",
  "description": "20251224T170000Z",
  "content": "",
  "source": "onclive.com",
  "source_url": "https://www.onclive.com/view/earlier-use-of-cdk4-6-inhibitors-oral-serds-reflects-shift-toward-proactive-management-of-hr-breast-cancer",
  "published_at": "20251224T170000Z",
  "fetched_at": "2025-12-25T00:22:49.565695+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.onclive.com/view/earlier-use-of-cdk4-6-inhibitors-oral-serds-reflects-shift-toward-proactive-management-of-hr-breast-cancer",
    "url_mobile": "",
    "title": "Earlier Use of CDK4 / 6 Inhibitors , Oral SERDs Reflects Shift Toward Proactive Management of HR+ Breast Cancer",
    "seendate": "20251224T170000Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/onclive/9a7375c7a575d660f86f45efe43cb03361f5f4f3-1280x720.png",
    "domain": "onclive.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}